Fighting Diseases

Latest News
June 01, 2023
Not intended for U.S. and UK Media
Bayer starts phase II/III study with vericiguat in children with heart failure
June 01, 2023
Not intended UK Media
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
May 31, 2023
Digital health solutions to drive transformation of everyday health:
Bayer launches unit to develop new precision health consumer products